Orthopedic Splints Market

Market Overview The global orthopedic splints market is projected to expand significantly, from USD 1.78 billion in 2025 to USD 2.64 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.79%. Orthopedic splints are essential medical devices, either rigid or flexible, designed to immobilize, support, and protect injured bones and soft tissues, thereby facilitating proper alignment and healing following trauma or surgery. This market's primary drivers include the rising incidence of musculoskeletal conditions and an aging population, which is increasingly susceptible to accidental falls and fractures. For example, in 2025, musculoskeletal disorders remained the most common workplace injury category in the United States, costing private sector employers nearly $18 billion annually, according to the National Safety Council. Furthermore, growing global participation in high-impact sports and recreational activities continues to necessitate effective immobilization solutions, thus bolstering product demand. Despite these strong growth catalysts, the market faces a significant challenge concerning clinical complications associated with prolonged device usage. Issues such as contact dermatitis, pressure ulcers, and potential nerve compression can severely impact patient comfort and compliance, often leading to reduced treatment adherence. This persistent problem forces healthcare providers to carefully balance the benefits of rigid immobilization against the risks of secondary dermatological or circulatory adverse events, consequently impeding broader market expansion, particularly within sensitive patient demographics. Market Driver The demand for orthopedic splints is primarily propelled by a rapidly aging global population and the concurrent prevalence of osteoporosis. As individuals age, their bone density significantly diminishes, rendering this demographic highly susceptible to fragility fractures from even minor incidents like low-impact falls. These physiological changes necessitate the frequent use of rigid immobilization devices to ensure correct anatomical alignment and facilitate healing without invasive surgery. According to the National Council on Aging's 'Get the Facts on Falls Prevention' report from May 2025, over one in four adults aged 65 and older falls each year, directly fueling the need for effective injury management solutions. This demographic shift consequently requires healthcare providers to stock a higher volume of supportive splints to address the escalating burden of geriatric trauma and fragility fractures. Concurrently, the rising rate of sports-related injuries and trauma significantly bolsters market growth, driven by increased global participation in high-impact recreational activities. Athletes are prone to acute musculoskeletal conditions, including severe sprains and fractures, which demand immediate stabilization to prevent further tissue damage and promote recovery. The National Safety Council reported in 2025 that sports and recreational injuries increased by 17% in 2024 following a period of steady growth, underscoring the critical necessity for accessible emergency splinting products. This upward trend in trauma cases translates into substantial financial expansion for leading orthopedic manufacturers, with Stryker reporting in January 2025 that net sales for their Trauma and Extremities segment increased by 11.4% to reach $3.5 billion, reflecting the intensifying consumption of immobilization devices within this high-acuity sector. Market Challenge The primary challenge hindering the growth of the global orthopedic splints market is the prevalence of clinical complications linked to prolonged device usage, such as contact dermatitis, pressure ulcers, and nerve compression. These adverse events significantly degrade patient comfort and often necessitate the premature removal or modification of the immobilization device, directly interrupting the continuity of care required for optimal bone healing. This disruption compels healthcare providers to prioritize tissue integrity over rigid stabilization, leading to hesitation in prescribing standard splinting solutions for patients with compromised skin or sensation, thereby narrowing the addressable market for these devices. The safety risks inherent in long-term immobilization create a substantial barrier to product adoption in acute care settings, where minimizing secondary hospital-acquired conditions is a critical financial and clinical priority. According to the National Pressure Injury Advisory Panel in 2025, medical device-related pressure injuries accounted for approximately 30% of all reported hospital-acquired pressure injuries. This high incidence rate highlights the significant liability and cost burden associated with rigid immobilization devices. Consequently, orthopedic facilities are increasingly cautious regarding widespread product utilization, effectively slowing market expansion within sensitive demographics. Market Trends The adoption of 3D printing technology for highly customized splints is revolutionizing the sector by effectively addressing the limitations of traditional casting methods. Manufacturers are increasingly leveraging additive manufacturing to create patient-specific immobilization devices that offer superior breathability, hygiene, and comfort compared to conventional plaster or fiberglass alternatives. This advanced technology enables clinicians to scan a patient's limb and fabricate a precise, waterproof splint in a fraction of the time required for conventional customization, significantly enhancing clinical workflow. The financial viability of this technological shift is evident in the performance of major industry players; for instance, Stratasys reported in August 2025 that sales of 3D printing systems grew to $30.6 million, reflecting the surging demand for additive manufacturing solutions across both the medical and industrial sectors. Concurrently, the rising preference for home-based and outpatient orthopedic care is reshaping product requirements, demanding more versatile and user-friendly immobilization solutions. As healthcare systems strive to reduce hospital admissions and associated costs, there is a distinct transition of procedures towards Ambulatory Surgery Centers (ASCs) and home recovery settings. This shift necessitates splints that are lightweight, removable, and easily managed by patients without constant professional supervision, thereby driving innovation in non-invasive support designs. This structural change in care delivery is a critical factor influencing overall market expansion; according to Gabelli's 'Orthopedics Market 2025 Update' from April 2025, the worldwide orthopedic market increased by 6% in 2024, a growth trajectory primarily sustained by the rapid expansion of procedure volumes within Ambulatory Surgery Centers. Key Market Players * Essity AB * Tri-Tech Forensics, Inc. * 3M Company * Otto Bock Healthcare GmbH * DeRoyal Industries Inc * medi GmbH & Co. KG * Zimmer Biomet Holdings Inc * Stryker Corporation * United MedicareBreg, Inc * Ossur hf Report Scope In this report, the Global Orthopedic Splints Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: # Orthopedic Splints Market, By Product * Fiberglass Splints * Plaster Splints * Tools & Accessories * Others # Orthopedic Splints Market, By Application * Lower Extremity * Upper Extremity # Orthopedic Splints Market, By End-user * Hospitals * Specialty Centers * Others # Orthopedic Splints Market, By Region * North America United States Canada Mexico * Europe France United Kingdom Italy Germany Spain * Asia Pacific China India Japan Australia South Korea * South America Brazil Argentina Colombia * Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in the Global Orthopedic Splints Market. Available Customizations: Global Orthopedic Splints Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: Company Information * Detailed analysis and profiling of additional market players (up to five).